Cingulate signs agreement to market its first drug candidate
March 13, 2023 at 08:49 AM EDT
The firm's first drug candidate will provide a once-daily treatment for ADHD.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Events | Directory | Real Estate | Blog | More
|